Back to trial details

Intake questionnaire

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

Applying to Saint Alphonsus Health System · Boise, Idaho

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Non-small Cell Lung Cancer (NSCLC)?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Boise for study visits?